Replimune Group Statistics
NASDAQ: REPLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
13.20-0.05 (-0.38%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Replimune Group by the numbers
Replimune Group has a market capitalization of $1.24 billion based on 94.22M shares outstanding. With trailing EPS of $-3.15, Replimune Group is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 0.9% below its 50-day average and 47.6% above its 200-day average.
Average daily trading volume is 4.20M shares, or about $55.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
REPL valuation vs. peer median
| Metric | REPL | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.24B | $1.36B | -8% |
| Avg. volume | 4.20M | 572.95K | +632% |
Peer median across 8 companies: COAG, IMTX, INBX, VOR, TSHA, MGTX, MAZE, IMCR.
Valuation
- Market cap
- $1.24B
- EPS (TTM)
- $-3.15
- Shares outstanding
- 94.22M
Price and trading
- Previous close
- 13.25
- Open
- 13.14
- Day range
- 13.02 – 13.60
- 52-week range
- 1.50 – 16.33
- 52-week change
- +183.87%
- Beta
- —
- Volume
- 1.65M
- Average volume
- 4.20M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 1.24B
- Forward Pe
- -7.26
- Eps
- -3.15
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 16.33
- Week52 Low
- 1.50
- Avg Volume
- 4.20M
- Shares Outstanding
- 94.22M
- Ma50
- 13.31
- Ma200
- 8.95
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -19.17%
- Pct From52w Low
- 780.00%